MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

Stryker Corp

Suletud

SektorTervishoid

373.03 0.21

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

366.01

Max

373.77

Põhinäitajad

By Trading Economics

Sissetulek

-288M

546M

Müük

946M

6.4B

P/E

Sektori keskmine

48.094

63.778

Aktsiakasum

4.01

Dividenditootlus

0.9

Kasumimarginaal

8.484

Töötajad

53,000

EBITDA

385M

1.8B

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+16.61% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.90%

2.39%

Järgmine tulemuste avaldamine

29. apr 2025

Järgmine dividendimakse kuupäev

30. apr 2025

Turustatistika

By TradingEconomics

Turukapital

-8.2B

142B

Eelmine avamishind

372.82

Eelmine sulgemishind

373.03

Uudiste sentiment

By Acuity

44%

56%

150 / 386 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Stryker Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

28. jaan 2025, 21:55 UTC

Tulu

Stryker Sees Further Organic Sales Growth in 2025

28. jaan 2025, 21:46 UTC

Omandamised, ülevõtmised, äriostud

Stryker to Sell Spinal Implants Business to Viscogliosi Brothers

6. jaan 2025, 22:18 UTC

Omandamised, ülevõtmised, äriostud

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion -- Update

6. jaan 2025, 21:39 UTC

Omandamised, ülevõtmised, äriostud

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion

19. veebr 2025, 13:53 UTC

Omandamised, ülevõtmised, äriostud

Stryker Files 8K - Asset Acquisition Or Disposition >SYK

19. veebr 2025, 13:30 UTC

Omandamised, ülevõtmised, äriostud

Stryker Completes Acquisition Of Inari Medical, Inc., Providing Entry Into The High-growth Peripheral Vascular Segment >SYK

28. jaan 2025, 21:09 UTC

Omandamised, ülevõtmised, äriostud

Stryker: Transaction Is Expected to Close in the U.S. in 1H 2025 >SYK

28. jaan 2025, 21:09 UTC

Omandamised, ülevõtmised, äriostud

Stryker: Agreement Includes Binding Offer to Acquire Stryker's Spinal Implants Business in France >SYK

28. jaan 2025, 21:08 UTC

Omandamised, ülevõtmised, äriostud

Stryker: After Closing, VB Spine Will Become a Strategic Partner to Stryker With Exclusive Access to Mako Spine and Copilot for Use With VB Spine's Implants in Spine Procedures >SYK

28. jaan 2025, 21:08 UTC

Omandamised, ülevõtmised, äriostud

Stryker: Agreement to Sell U.S. Spinal Implants Business to Viscogliosi Brothers, LLC to Create Newly Formed Co Called VB Spine, LLC >SYK

28. jaan 2025, 21:06 UTC

Tulu

Stryker Sees Organic Net Sales Growth of 8% to 9% for 2025 >SYK

28. jaan 2025, 21:06 UTC

Tulu

Stryker Sees FY Adj EPS $13.45-Adj EPS $13.70 >SYK

28. jaan 2025, 21:05 UTC

Omandamised, ülevõtmised, äriostud

Stryker: Announces Definitive Agreement for the Sale of U.S. Spinal Implants Business and Plans to Sell Related Intl Business

28. jaan 2025, 21:05 UTC

Tulu

Stryker 4Q Net $500M >SYK

28. jaan 2025, 21:05 UTC

Tulu

Stryker 4Q Adj EPS $4.01 >SYK

28. jaan 2025, 21:05 UTC

Tulu

Stryker 4Q Net $546M >SYK

28. jaan 2025, 21:05 UTC

Tulu

Stryker 4Q Net $500M >SYK

28. jaan 2025, 21:05 UTC

Tulu

Stryker 4Q Sales $6.4B >SYK

28. jaan 2025, 21:05 UTC

Tulu

Stryker 4Q EPS $1.41 >SYK

28. jaan 2025, 21:05 UTC

Tulu

Stryker 4Q Adj EPS $4.01 >SYK

28. jaan 2025, 21:05 UTC

Tulu

Stryker 4Q EPS $1.41 >SYK

28. jaan 2025, 21:05 UTC

Tulu

Stryker 4Q Sales $6.4B >SYK

17. jaan 2025, 21:20 UTC

Omandamised, ülevõtmised, äriostud

Stryker Commences Tender Offer for All Outstanding Shrs of Common Stock of Inari Medical

13. jaan 2025, 19:30 UTC

Tulu

Update: Stryker Had A Good Year Last Year; Here's How It's Looking For 2025 -- IBD

7. jaan 2025, 09:58 UTC

Kuumad aktsiad

Stocks to Watch Tuesday: Nvidia, Uber, Tencent -- WSJ

6. jaan 2025, 22:03 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

Stryker to Acquire Inari Medical in Deal Valued at $4.9B -- Update

6. jaan 2025, 21:49 UTC

Omandamised, ülevõtmised, äriostud

Inari Medical Catapults -- Again -- After Stryker Confirms $4.9 Billion Deal -- IBD

6. jaan 2025, 21:24 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

Stryker to Acquire Inari Medical in Deal Valued at $4.9B

6. jaan 2025, 21:11 UTC

Omandamised, ülevõtmised, äriostud

Stryker: Inari's Innovative Pdt Portfolio Is Highly Complementary to Our Neurovascular Business >SYK

6. jaan 2025, 21:10 UTC

Omandamised, ülevõtmised, äriostud

Stryker: Transaction Is Anticipated to Close by the End of the 1Q >SYK

Võrdlus sarnastega

Hinnamuutus

Stryker Corp Prognoos

Hinnasiht

By TipRanks

16.61% tõus

12 kuu keskmine prognoos

Keskmine 435.3 USD  16.61%

Kõrge 465 USD

Madal 400 USD

Põhineb 22 Wall Streeti analüütiku instrumendi Stryker Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

22 ratings

18

Osta

4

Hoia

0

Müü

Tehniline skoor

By Trading Central

372.77 / 374.61Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Neutral Evidence

Sentiment

By Acuity

150 / 386 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.